tirzepatide from lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity A Study of Tirzepatide (LY3298176)

How might combining liraglutide therapy with exercise amplify its benefits, and what implications does this have for developing comprehensive treatment plans for patients with obesity or Type 2 diabetes

Hydration recommendations form the cornerstone of prevention: Fluid intake targets : Patients should aim for sufficient fluid intake to produce at least 2.5 liters of urine daily, in accordance with American Urological Association guidelines

Journal of Clinical Endocrinology & Metabolism , 105(3), e123-e138

That number gets quoted constantly in marketing copy, but it hides three things every prospective patient should know: results depend heavily on dose, real-world losses tend to be smaller, and the weight comes back fast if you stop the drug